| L - Antineoplastic and Immunomodulating Agents | This group comprises preparations used in the treatment of neoplastic diseases, and immunomodulating agents.
Corticosteroids for systemic use, see H02.
|
| | L03 - Immunostimulants | Immunosuppressants, see L04A.
|
| | L03A - Immunostimulants | Levamisole, which also affects the immune response, is classified in P02CE.
|
| | L03AX - Other Immunostimulants | | | The DDD for tasonermin is based on single dose treatment.
The DDD of 0.5 mg (P) for histamine dihydrochloride is based on the total dose devided by days of first treatment cycle (42 days).
|
|
|
